PHARMADECOR
ActiveSummary
PHARMADECOR has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.9m and a net result of €121,629. Equity is growing by about 6.3% per year across the filed financial years. Its solvency ranks better than 95% of 9,723 sector peers (NACE 43, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 28 days late
2025
31-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
25-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
20-07
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial
Highest result from 2018 to 2025net €288,999 ▲32.5%
Operating result €356,379, net result €288,999, both a record.
25-05
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
18-06
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
31-12
Financial
Liquidity more than 13 timescurrent ratio 30.39
Current ratio from 2.33 to 30.39; short-term debt falls from €2.1m to €96,951.
26-06
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
29-08
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format · 29 days late
2018
28-06
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
31-05
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 45 annual accounts filed, the latest 10 are here; all 45 are under Financials.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.